Providence Medical Technology closed a US $10.5MM new equity financing round. Proceeds will support commercialization and expansion of cervical fusion products. Previous fundings included $6.8MM in 2014 and $12.0MM in 2015.
The company’s line includes DTRAX® spinal systems, CAVUX™ cervical cages, ALLY™ screw systems and BIOLOGIX™ allograft bone, provided in single-use sterile packaging.
Participants included new investor MVM Life Science Partners leading the transaction, accompanied by Stanmore Medical Investments, Aphelion Capital and existing private investors.
Providence Medical Technology closed a US $10.5MM new equity financing round. Proceeds will support commercialization and expansion of cervical fusion products. Previous fundings included $6.8MM in 2014 and $12.0MM in 2015.
The company's line includes DTRAX® spinal systems, CAVUX™ cervical cages, ALLY™ screw systems and BIOLOGIX™ allograft...
Providence Medical Technology closed a US $10.5MM new equity financing round. Proceeds will support commercialization and expansion of cervical fusion products. Previous fundings included $6.8MM in 2014 and $12.0MM in 2015.
The company’s line includes DTRAX® spinal systems, CAVUX™ cervical cages, ALLY™ screw systems and BIOLOGIX™ allograft bone, provided in single-use sterile packaging.
Participants included new investor MVM Life Science Partners leading the transaction, accompanied by Stanmore Medical Investments, Aphelion Capital and existing private investors.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
